TerminatedNot Applicable

Clinical Trial of PSORI-CM01（YXBCM01） Granule to Treat Stable Plaque Psoriasis

Stopped: Paitents were unwilling to be randomly assigned to a placebo group.

China35 participantsStarted 2013-12

Plain-language summary

The purpose of this study is to evaluate the efficacy and safety of Chinese herbal PSORI-CM01（YXBCM01） granule for stable plaque psoriasis, with blood stasis syndrome of Chinese Medicine.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Stable plaque psoriasis, duration \> 1 year.
✓. Patients with Chinese medicine blood stasis syndrome. (2)18 to 65 years old, male or female patient.
✓. Mild psoriasis:3\<PASI≤10, and BSA≤10%.
✓. Informed consent.

Exclusion criteria

✕. Guttate psoriasis, inverse psoriasis or exclusively involves the face;
✕. Acute progression of psoriasis, and erythroderma tendency.Not blood stasis syndrome.Not stable psoriasis.
✕. Pregnant, lactating, or which one plan to become pregnant in a year;
✕. SAS（Self-rating Anxiety Scale）\> 50 or SDS（Self-rating Depression Scale）\> 53, or with other psychiatric disorders;
✕. With history of cardiovascular, respiratory, digestive, urinary, and hematologic disease, which can't controlled through common treatment. Either with cancer, infection, electrolyte imbalance, acid-base disturbance and calcium metabolic disorder.
✕. Allergic to any medicine or ingredients used in this study.
✕. Participating other clinical trials or participated within 1 month.
✕. Topical treatments (i.e. corticosteroids, Retinoic acid) within 2 weeks; systemic therapy or phototherapy (UVB and PUVA) within 4 weeks; biological therapy within 12 weeks.

What they're measuring

PASI-50

Timeframe: 12 weeks (plus or minus 3 days) after treatment

Trial details

NCT IDNCT02153840

SponsorGuangdong Provincial Hospital of Traditional Chinese Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-11

View on ClinicalTrials.gov More Plaque Psoriasis trials